David Sidransky

USPTO Granted Patents = 37 (Patent Applications = 10)

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 5)

Average Co-Inventor Count = 1.6

ph-index = 10

Forward Citations = 565(Granted Patents)

Company Filing History:

37 out of 3,685

Johns Hopkins University

The United States of America, As Represented by the Secretary, Department of Health and Human Services

The U.s.a. As Represented by the Secretary of the Hhs

patent

6. 1 out of 8

Esoterix Genetic Laboratories, LLC

patents

where one patent can have more than one assignee

Years Active: 1996-2021

Loading Chart...

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10888549 - Pharmaceutical agents targeting cancer stem cells (2021-01-12),

2. 10801071 - TGF(β)-MIR200-MIG6 pathway and its use in the treatment of cancer as an indicator of resistance to EGFR inhibitors (2020-10-13),

3. 10457992 - Hypermethylation biomarkers associated with poor survival outcomes for head and neck squamous cell cancer (2019-10-29),

4. 10428391 - Method to use viral and host methylation markers for cervical cancer screening and triage in liquid prep, serum/plasma, and urine: PCR and sequencing based process methods (2019-10-01),

5. 9809864 - Dual sequence-capture method for quantifying trans renal HPV DNA in urine (2017-11-07),

6. 9328379 - Hypermethylation biomarkers for detection of head and neck squamous cell cancer (2016-05-03),

7. 8859468 - Hypermethylation biomarkers for detection of cervical cancer (2014-10-14),

8. 8728732 - Global DNA hypomethylation and biomarkers for clinical indications in cancer (2014-05-20),

9. 8617809 - Neoplasia screening compositions and methods of use (2013-12-31),

10. 8067240 - Methods for the diagnosis and treatment of lung cancer (2011-11-29),

11. 7923460 - [object Object] (2011-04-12),

12. 7846667 - Methods for the diagnosis and treatment of lung cancer (2010-12-07),

13. 7794929 - Genomic screen for epigenetically silenced genes associated with cancer (2010-09-14),

14. 7781161 - Genomic screen for epigenetically silenced tumor suppressor genes (2010-08-24),

15. 7709202 - Molecular characteristics of non-small cell lung cancer (2010-05-04),

Title: The Innovative Journey of David Sidransky

Introduction: David Sidransky, a distinguished inventor hailing from Baltimore, MD, has made significant contributions to the field of medicine and biotechnology through his groundbreaking innovations.

Latest Patents: David Sidransky holds several patents in the medical and biotech sectors, focusing on novel diagnostic tools and therapeutic solutions that have the potential to revolutionize healthcare practices.

Career Highlights: With a career spanning several decades, David Sidransky has established himself as a leading figure in the realm of medical innovation. His work has not only garnered recognition within the scientific community but has also positively impacted the lives of many individuals worldwide.

Collaborations: Throughout his career, David Sidransky has collaborated with top research institutions, universities, and biotech companies to further his research and bring his inventions to fruition. His collaborative efforts have led to the development of cutting-edge technologies that have the potential to shape the future of healthcare.

Conclusion: David Sidransky's relentless pursuit of innovation and his unwavering commitment to advancing medical science have solidified his position as a pioneering inventor in the field. His contributions continue to inspire future generations of inventors and researchers to push the boundaries of what is possible in the world of medicine and biotechnology.

This text is generated by artificial intelligence and may not be accurate.